# A Study of Oxidative Pathways in MS Fatigue

> **NCT02804594** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 15 (actual)

## Conditions studied

- Progressive Multiple Sclerosis
- Fatigue

## Interventions

- **DRUG:** N-acetyl cysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02804594
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-01
- **Primary completion:** 2018-06-01
- **Final completion:** 2018-06-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02804594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02804594, "A Study of Oxidative Pathways in MS Fatigue". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02804594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*